CD22 is required for formation of memory B cell precursors within germinal centers
CD22 is a BCR co-receptor that regulates B cell signaling, proliferation and survival and is required for T cell-independent Ab responses. To investigate the role of CD22 during T cell-dependent (TD) Ab responses and memory B cell formation, we analyzed Ag-specific B cell responses generated by wild...
Saved in:
Published in | PloS one Vol. 12; no. 3; p. e0174661 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
27.03.2017
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | CD22 is a BCR co-receptor that regulates B cell signaling, proliferation and survival and is required for T cell-independent Ab responses. To investigate the role of CD22 during T cell-dependent (TD) Ab responses and memory B cell formation, we analyzed Ag-specific B cell responses generated by wild-type (WT) or CD22-/- B cells following immunization with a TD Ag. CD22-/- B cells mounted normal early Ab responses yet failed to generate either memory B cells or long-lived plasma cells, whereas WT B cells formed both populations. Surprisingly, B cell expansion and germinal center (GC) differentiation were comparable between WT and CD22-/- B cells. CD22-/- B cells, however, were significantly less capable of generating a population of CXCR4hiCD38hi GC B cells, which we propose represent memory B cell precursors within GCs. These results demonstrate a novel role for CD22 during TD humoral responses evident during primary GC formation and underscore that CD22 functions not only during B cell maturation but also during responses to both TD and T cell-independent antigens. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Conceptualization: CPC EAC.Data curation: CPC KED.Formal analysis: CPC KED.Funding acquisition: EAC.Investigation: CPC KED.Methodology: CPC KED EAC.Project administration: EAC.Resources: CPC EAC.Supervision: EAC.Validation: CPC KED.Visualization: CPC KED.Writing – original draft: CPC.Writing – review & editing: CPC EAC. Competing Interests: The authors have declared that no competing interests exist. Current address: Immunology Discovery at Merck Research Laboratories, Boston, Massachusetts |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0174661 |